BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8660911)

  • 1. c-Myc and Max interactions in quiescent and mitogen-stimulated primary hepatocytes.
    Skouteris GG; Schröder CH
    Exp Cell Res; 1996 Jun; 225(2):237-44. PubMed ID: 8660911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of myc-max-mad gene expression during hepatocyte proliferation in vivo: Differential regulation of mad family and stress-mediated induction of c-myc.
    Mauleon I; Lombard MN; Muñoz-Alonso MJ; Cañelles M; Leon J
    Mol Carcinog; 2004 Feb; 39(2):85-90. PubMed ID: 14750213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Myc does not require max for transcriptional activity in PC-12 cells.
    Ribon V; Leff T; Saltiel AR
    Mol Cell Neurosci; 1994 Jun; 5(3):277-82. PubMed ID: 8087425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mad1 expression in the absence of differentiation: effect of cAMP on the B-lymphoid cell line Reh.
    Naderi S; Blomhoff HK
    J Cell Physiol; 1999 Jan; 178(1):76-84. PubMed ID: 9886493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Max and c-Myc/Max DNA-binding activities in cell extracts.
    Littlewood TD; Amati B; Land H; Evan GI
    Oncogene; 1992 Sep; 7(9):1783-92. PubMed ID: 1501888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of Max and role of c-Myc during erythroid and myelomonocytic differentiation of K562 cells.
    Delgado MD; Lerga A; Cañelles M; Gómez-Casares MT; León J
    Oncogene; 1995 Apr; 10(8):1659-65. PubMed ID: 7731722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low molecular weight inhibitors of Myc-Max interaction and function.
    Yin X; Giap C; Lazo JS; Prochownik EV
    Oncogene; 2003 Sep; 22(40):6151-9. PubMed ID: 13679853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of the widely expressed dMax splice variant of Max on E-box vs initiator element-mediated regulation by c-Myc.
    FitzGerald MJ; Arsura M; Bellas RE; Yang W; Wu M; Chin L; Mann KK; DePinho RA; Sonenshein GE
    Oncogene; 1999 Apr; 18(15):2489-98. PubMed ID: 10229200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of c-Myc and Max in megakaryocytic and monocytic-macrophagic differentiation of K562 cells induced by protein kinase C modifiers: c-Myc is down-regulated but does not inhibit differentiation.
    Lerga A; Crespo P; Berciano M; Delgado MD; Cañelles M; Calés C; Richard C; Ceballos E; Gutierrez P; Ajenjo N; Gutkind S; León J
    Cell Growth Differ; 1999 Sep; 10(9):639-54. PubMed ID: 10511314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. myc, max, and a novel rlf-L-myc fusion protein in small-cell lung cancer.
    Västrik I; Mäkelä TP; Koskinen PJ; Saksela K; Alitalo K
    Princess Takamatsu Symp; 1991; 22():307-18. PubMed ID: 1668890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the DNA-binding activities of Myc/Max/Mad network complexes during induced differentiation of U-937 monoblasts and F9 teratocarcinoma cells.
    Larsson LG; Bahram F; Burkhardt H; Lüscher B
    Oncogene; 1997 Aug; 15(6):737-48. PubMed ID: 9264414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Myc/Max/Mad network members in adipogenesis: inhibition of the proliferative burst and differentiation by ectopically expressed Mad1.
    Pulverer B; Sommer A; McArthur GA; Eisenman RN; Lüscher B
    J Cell Physiol; 2000 Jun; 183(3):399-410. PubMed ID: 10797315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of casein kinase II phosphorylation sites in Max: effects on DNA-binding kinetics of Max homo- and Myc/Max heterodimers.
    Bousset K; Henriksson M; Lüscher-Firzlaff JM; Litchfield DW; Lüscher B
    Oncogene; 1993 Dec; 8(12):3211-20. PubMed ID: 8247525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of max by adrenomedullin and calcitonin gene-related peptide antagonizes endothelial apoptosis.
    Shichiri M; Kato H; Doi M; Marumo F; Hirata Y
    Mol Endocrinol; 1999 Aug; 13(8):1353-63. PubMed ID: 10446908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YY1 can inhibit c-Myc function through a mechanism requiring DNA binding of YY1 but neither its transactivation domain nor direct interaction with c-Myc.
    Austen M; Cerni C; Lüscher-Firzlaff JM; Lüscher B
    Oncogene; 1998 Jul; 17(4):511-20. PubMed ID: 9696045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific c-myc and max regulation in epithelial cells.
    Martel C; Lallemand D; Crémisi C
    Oncogene; 1995 Jun; 10(11):2195-205. PubMed ID: 7784064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic induction of the Fas (CD95) ligand promoter by Max and NFkappaB in human non-small lung cancer cells.
    Wiener Z; Ontsouka EC; Jakob S; Torgler R; Falus A; Mueller C; Brunner T
    Exp Cell Res; 2004 Sep; 299(1):227-35. PubMed ID: 15302589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myc drives apoptosis in PC12 cells in the absence of Max.
    Wert M; Kennedy S; Palfrey HC; Hay N
    Oncogene; 2001 Jun; 20(28):3746-50. PubMed ID: 11439337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation.
    Lüscher B; Larsson LG
    Oncogene; 1999 May; 18(19):2955-66. PubMed ID: 10378692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immediate early gene expression in dog thyrocytes in response to growth, proliferation, and differentiation stimuli.
    Deleu S; Pirson I; Clermont F; Nakamura T; Dumont JE; Maenhaut C
    J Cell Physiol; 1999 Nov; 181(2):342-54. PubMed ID: 10497313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.